HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Yatomi Selected Research

Lysophospholipids

2/2023Usefulness of lysophosphatidylcholine measurement in the cerebrospinal fluid for differential diagnosis of neuropathic pain: Possible introduction into clinical laboratory testing.
1/2023Modulations of urinary lipid mediators in acute bladder cystitis.
12/2022Decrease in serum levels of autotaxin in COVID-19 patients.
11/2022Autotaxin is a potential link between genetic risk factors and immunological disturbances of plasmacytoid dendritic cells in systematic lupus erythematosus.
1/2022Understanding modulations of lipid mediators in cancer using a murine model of carcinomatous peritonitis.
2/2021Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A1 in patients with lupus nephritis.
4/2020Elevated phosphatidylserine-specific phospholipase A1 level in hyperthyroidism.
1/2020Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma.
1/2019Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis.
5/2018Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Yatomi Research Topics

Disease

42Neoplasms (Cancer)
04/2023 - 11/2004
18Fibrosis (Cirrhosis)
01/2023 - 04/2006
16Inflammation (Inflammations)
02/2023 - 10/2008
15Hepatocellular Carcinoma (Hepatoma)
01/2023 - 10/2011
14COVID-19
07/2023 - 01/2021
12Liver Cirrhosis (Hepatic Cirrhosis)
03/2019 - 09/2007
11Acute Coronary Syndrome
09/2019 - 12/2011
10Atherosclerosis
01/2023 - 11/2010
9Hypertension (High Blood Pressure)
01/2022 - 09/2007
8Diabetic Nephropathies (Diabetic Nephropathy)
01/2023 - 01/2010
8Neoplasm Metastasis (Metastasis)
10/2017 - 01/2006
7Wounds and Injuries (Trauma)
10/2023 - 01/2007
7Obesity
02/2023 - 12/2013
6Hemorrhage
02/2024 - 08/2005
6Infections
11/2022 - 06/2011
6Lymphoma (Lymphomas)
08/2022 - 10/2008
6Colonic Neoplasms (Colon Cancer)
01/2022 - 02/2015
6Glaucoma
06/2021 - 01/2018
6Thrombosis (Thrombus)
01/2020 - 08/2010
6Chronic Hepatitis C
01/2018 - 07/2007
6Liver Diseases (Liver Disease)
01/2018 - 11/2009
6Stomach Neoplasms (Stomach Cancer)
10/2017 - 11/2004
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2016 - 12/2011
5Thrombocytopenia (Thrombopenia)
09/2023 - 08/2010
5Autoimmune Diseases (Autoimmune Disease)
11/2022 - 01/2011
5Melanoma (Melanoma, Malignant)
02/2021 - 07/2007
4Neuralgia (Stump Neuralgia)
02/2023 - 01/2018
4Cardiovascular Diseases (Cardiovascular Disease)
12/2022 - 11/2012
4Heart Failure
10/2021 - 07/2012
4Diabetes Mellitus
07/2021 - 07/2018
4Insulin Resistance
01/2021 - 09/2014
4Adenocarcinoma of Lung
10/2018 - 06/2017
4Body Weight (Weight, Body)
02/2018 - 03/2009
4Stable Angina
09/2017 - 11/2012
4Lung Neoplasms (Lung Cancer)
09/2014 - 12/2009
3IGA Glomerulonephritis (IGA Nephropathy)
02/2024 - 01/2019
3Sepsis (Septicemia)
10/2023 - 01/2018
3Pain (Aches)
02/2023 - 01/2018
3Pathologic Constriction (Stenosis)
01/2023 - 11/2019
3Type 2 Diabetes Mellitus (MODY)
12/2022 - 02/2009
3Open-Angle Glaucoma (Glaucoma, Open Angle)
12/2021 - 01/2021
3Disease Progression
09/2021 - 01/2013

Drug/Important Bio-Agent (IBA)

42Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2006
26sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
10/2023 - 04/2003
26LipidsIBA
01/2023 - 04/2002
25lysophosphatidic acidIBA
12/2023 - 09/2006
21Messenger RNA (mRNA)IBA
01/2022 - 09/2007
19LysophospholipidsIBA
02/2023 - 04/2003
19EnzymesIBA
01/2023 - 07/2007
13Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
02/2023 - 07/2007
12AlbuminsIBA
01/2023 - 01/2017
12AntigensIBA
08/2022 - 08/2005
12Proteins (Proteins, Gene)FDA Link
02/2022 - 09/2007
11SphingosineIBA
12/2022 - 01/2007
10SphingolipidsIBA
01/2024 - 04/2002
10CeramidesIBA
01/2024 - 01/2018
9lysophosphatidylserineIBA
11/2022 - 10/2014
8Phosphates (Orthophosphate)IBA
01/2024 - 01/2007
8PhosphatidylserinesIBA
11/2022 - 01/2017
7Choline (Choline Chloride)IBA
01/2023 - 07/2007
7AntibodiesIBA
02/2022 - 02/2011
7Immunoglobulin M (IgM)IBA
02/2022 - 08/2013
7Phospholipases A1 (Phospholipase A1)IBA
02/2021 - 01/2017
7alkylglycerophosphoethanolamine phosphodiesteraseIBA
01/2018 - 07/2006
6LipopolysaccharidesIBA
10/2023 - 01/2015
6Indicators and Reagents (Reagents)IBA
11/2022 - 02/2012
6Alanine Transaminase (SGPT)IBA
04/2022 - 09/2007
6Immunoglobulin G (IgG)IBA
02/2022 - 01/2021
5Protein Isoforms (Isoforms)IBA
01/2022 - 05/2013
5LyasesIBA
01/2022 - 12/2013
5Hyaluronic Acid (Hyaluronan)IBA
01/2020 - 05/2010
5MicroRNAs (MicroRNA)IBA
10/2018 - 12/2011
5Sphingosine-1-Phosphate ReceptorsIBA
09/2014 - 01/2006
4Immunoglobulin A (IgA)IBA
02/2024 - 01/2019
4Apolipoproteins MIBA
10/2023 - 01/2019
4Histones (Histone)IBA
10/2023 - 10/2015
4HDL LipoproteinsIBA
10/2023 - 01/2016
4DNA (Deoxyribonucleic Acid)IBA
10/2023 - 04/2010
4Phospholipids (Phosphatides)FDA LinkGeneric
12/2022 - 02/2011
4fibrin fragment D (D-dimer)IBA
12/2022 - 12/2017
4oxidized low density lipoproteinIBA
12/2022 - 11/2010
4lysophosphatidylinositolIBA
11/2022 - 01/2017
4SphingomyelinsIBA
11/2022 - 11/2012
4CholesterolIBA
07/2021 - 11/2010
4mercaptoalbuminIBA
01/2021 - 01/2018
4SaltsIBA
11/2020 - 05/2011
4Carbon Tetrachloride (Tetrachloromethane)IBA
05/2010 - 09/2007
3SteroidsIBA
09/2023 - 01/2018
3RNA (Ribonucleic Acid)IBA
04/2023 - 06/2017
3EicosanoidsIBA
01/2023 - 01/2021
3Triglycerides (Triacylglycerol)IBA
12/2022 - 02/2015
3Glycerophospholipids (Phosphoglycerides)IBA
11/2022 - 01/2022
3lysophosphatidylglycerolIBA
11/2022 - 01/2017
3Glucose (Dextrose)FDA LinkGeneric
08/2022 - 02/2009
3Hexosaminidases (Hexosaminidase)IBA
04/2022 - 03/2020
3Fibrinogen (Factor I)FDA Link
04/2021 - 06/2006
3Serum AlbuminIBA
01/2021 - 11/2018

Therapy/Procedure

13Therapeutics
05/2023 - 01/2007
4Drug Therapy (Chemotherapy)
01/2018 - 08/2013
3Transplantation
06/2023 - 08/2010